WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying cellular technology in the field of regenerative medicine, announced that company Chairman and Chief Executive Officer William M. Caldwell IV was interviewed yesterday on Bloomberg Radio\'s popular mid-day program, The Hays Advantage, hosted by Kathleen Hays. The discussion covered Advanced Cell’s retinal pigment epithelium (RPE) cell program for the treatment of Stargardt&
For more information, please visit
http://www.businesswire.com/news/home/20100310005784/en